Influence of molecular dipoles on human skin permeability: Use of 6-ketocholestanol to enhance the transdermal delivery of bacitracin

Journal of Pharmaceutical Sciences

Volumn 92, Issue 5, 2003, Pages 1018-1027

  Cladera, Josep ^a   O'Shea, Paul ^a   Hadgraft, Jonathan ^b   Valenta, Claudia ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

6 ketocholestanol; Bacitracin; Di 8 ANEPPS; Fluoresceinphosphatidylethanolamine; Membrane dipole potential; Transdermal delivery

Indexed keywords

1 (3 SULFONATOPROPYL) 4 [BETA [2 (DI N OCTYLAMINO) 6 NAPHTHYL]VINYL]PYRIDINIUM BETAINE; 6 OXOCHOLESTANOL; BACITRACIN; CHOLESTANOL; FLUORESCEINPHOSPHATIDYLETHANOLAMINE; LIPOSOME; PHLORETIN; PHOSPHATIDYLETHANOLAMINE; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; DIPOLE; DRUG PENETRATION; DRUG STRUCTURE; ELECTRICITY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; MEMBRANE POTENTIAL; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0037408151     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10344     Document Type: Article

References (35)

1. Swartzendruber DC, Wertz PW, Madison KC, Downing DT. 1987. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 88:709-713.
2. Wertz PW, Miethke MC, Long SA, Strauss JS, Downing DT. 1985. The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol 84:410-412.
3. Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Control Release 6:85-97.
4. Smith EW, Maibach HI. 1995. Percutaneous penetration enhancers: The fundamentals. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. New York: CRC Press, pp 1-19.
5. Walters KA. 1989. Penetration enhancers and their use in transdermal therapeutic systems. In: Hadgraft J, Guy RH, editors. Transdermal drug delivery, development issues and research initiatives. New York: Marcel Dekker, pp 197-247.
6. Ando HY, Schultz TW, Schnaare RL, Sugita ET. 1984. Percutaneous absorption: A new physicochemical predictive model for maximum human in vivo penetration rates. J Pharm Sci 73(4):461-467.
7. Obata Y, Li CJ, Fujikawa M, Takayama K, Sato H, Higashiyama K, Isowa K, Nagai T. 2001. Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network. Int J Pharm 212:223-231.
8. Lim CW, Fujiwara S, Yamashita F, Hashida M. 2002. Prediction of human skin permeability using a combination of molecular orbital calculations and artificial neural network. Biol Pharm Bull 25:361-366.
9. Liron Z, Cohen S. 1984. Percutaneous absorption of alkanoic acids. I. A study of operational conditions. J Pharm Sci 73:534-537.
10. Liron Z, Cohen S. 1984. Percutaneous absorption of alkanoic acids. II. Application of regular solution theory. J Pharm Sci 73:538-542.
11. Franklin JC, Cafiso DS. 1993. Internal electrostatic potentials in bilayers: Measuring and controlling dipole potentials in lipid vesicles. Biophys J 65: 289-299.
12. Gross E, Bedlack RS, Loew LM. 1994. Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys J 67: 208-216.
13. Cladera J, O'Shea P. 1998. Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide. Biophys J 74:2434-2442.
14. Valenta C, Cladera J, O'Shea P, Hadgraft J. 2001. Effect of phloretin on the percutaneous absorption of lignocaine across human skin. J Pharm Sci 90: 485-492.
15. Brockman H. 1994. Dipole potential of lipid membranes. Chem Phys Lipids 73:57-59.
16. Voglino L, Mcintosh TJ, Simon SA. 1998. Modulation of the binding of signal peptides to lipid bilayers by dipoles near the hydrocarbon-water interface. Biochemistry 37:12241-12252.
17. Cladera J, Martin I, Ruysschaert JM, O'Shea P. 1999. Characterization of the sequence of interactions of the fusion domain of the simian immunodeficiency virus with membranes. J Biol Chem 274: 29951-29959.
18. Rokitskaya TL, Antonenko YN, Kotova EA. 1997. Effect of the dipole potential of a bilayer lipid membrane on gramicidin channel dissociation kinetics. Biophys J 73:850-854.
19. Shapovalov V, Kotova EA, Rokitskaya TI, Antonenko YN. 1999. Effect of gramicidin A on the dipole potential of phospholipid membranes. Biophys J 77:299-305.
20. Maggio B. 1999. Modulation of phospholipase A2 by electrostatic fields and dipole potential of glycosphingolipids in monolayers. J Lipid Res 40:930-939.
21. Cladera J, O'Shea P. 2001. Generic techniques for fluorescence measurements of protein-ligand interactions: real-time kinetics and spatial imaging. In: Harding SE, Chowdery BZ, editors. Protein-ligand interactions. Oxford, UK: Oxford University Press, pp 169-200.
22. Mayer LD, Hope MJ, Cullis PR. 1986. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 858:161-168.
23. Wall J, Golding C, Van Veen M, O'Shea P. 1995. The use of fluoresceinphosphatidylethanolamine as a real time probe of peptide-membrane interactions. Mol Membr Biol 12:183-192.
24. Tsuji K, Robertson JH. 1975. Improved highperformance liquid chromatographic method for polypeptide antibiotics and its application to study the effects of treatments to reduce microbial levels in bacitracin powder. J Chromatogr 112: 663-672.
25. Wall J, Ayoub F, O'Shea P. 1995. The interactions of macromolecules with mammalian cell surface. J Cell Sci 108:2673-2682.
26. Golding C, Senior S, Wilson MT, O'Shea P. 1996. Time resolution of binding and insertion of a mitochondrial signal peptide: Correlation with structural changes and evidence for cooperativity. Biochemistry 35:10931-10937.
27. Wolfe CA, Cladera J, O'Shea P. 1998. Amino acid sequences which promote and prevent the binding and membrane insertion of surface active peptides: Comparison of melittin and promelittin. Mol Membr Biol 15:221-227.
28. Wolfe CA, Cladera J, Ladha S, Senior S, Jones R, O'Shea P. 1999. Membrane interactions of the putative fusion peptide (MF alpha P) from fertilin-alpha, the mouse sperm protein complex involved in fertilization. Mol Membr Biol 16:257-263.
29. Loew LM, Scully S, Simpson L, Waggoner AS. 1979. Evidence for a charge shift electrochromic mechanism in a probe of membrane potential. Nature 281: 497-499.
30. Martin I, Schaal H, Scheid A, Ruysschaert JM. 1996. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol 70:298-304.
31. Bradshaw JP, Darkes MJ, Haroun TA, Katsaras J, Epand RM. 2000. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry 39:6581-6585.
32. Dempsey CE, Watts A. 1987. A deuterium and phosphorus-31 nuclear magnetic resonance study of the interaction of melittin with dimyristoylphosphatidylcholine bilayers and the effects of contaminating phospholipase A2. Biochemistry 26: 5803-5811.
33. Beschiaschvili G, Seelig J. 1990. Melittin binding to mixed phosphatidylglycerol phosphatidylcholine membranes. Biochemistry 29:52-58.
34. 31P NMR study of phloretin and phloretin analogues in phosphatidylcholine membranes. Biochemistry 30:3923-3929.
35. Simon SA, Macintosh TJ, Magid AD, Neddham D. 1992. Modulation of the interbilayer hydration pressure by the addition of dipoles at the hydrocarbon/water interface. Biophys J 61:786-799.